Pregabalin Capsule
Product Images NDC 71335-1789

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351789)

Label (Lbl713351789)
This is a medication packaging of Pregabalin, USP, which comes in capsule form with 100mg per capsule. The label includes the medication name and strength, safety precautions including the need to keep it out of reach of children, and storage instructions. The product is manufactured by H BRP Pharmaceuticals and comes in a pack of 30 capsules.*
FDA Label Image

Label (Lbl7133517892)

Label (Lbl7133517892)
This text appears to be a package label for a medication called "Pachaged" which is packaged by Bryant Ranck Prepack. The label includes information to compare the medication to "Lyrica 100mg" in capsule form made by Hetero Labs Limited. The package contains 30 capsules with an expiration date of MM/YY and the product's National Drug Code (NDC) is 7133517891. The package also includes a manufacturer's address in Burbank, CA and storage instructions to keep the medication at room temperature between 20°-25°C (68°-77°F). Lastly, there is a warning to keep all drugs out of reach of children.*
FDA Label Image
FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

Pregabalinfigure2 (Pregabalinfigure2)
Percent of Patients Improved. Percent Improvement in Pain from Baseline.*
FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

Pregabalinfigure4 (Pregabalinfigure4)
This is a chart showing the percentage of patients improved in pain from baseline after taking Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and a placebo. The chart contains numerical values on the x-axis from 50 to 300 and on the y-axis from 5 to 100, representing the percentage of improvement.*
FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.